Description: Trevena Inc. is a clinical stage biopharmaceutical company in King of Prussia, Pennsylvania, involved in the discovery and development of GPCR biased ligands.
Description: Trevena, Inc. is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G-protein coupled receptor (GPCR) targeted medicines.